StockData
Valneva SE logo

Valneva SE (VALN) stock

VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 17, 2026Score 1/30
$5.66−0.10 (-1.74%)

Close on Nov 13, 2026Market cap $491.12MP/E –Yield –

Valneva statistics

61 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Valuation ratiosIndustry

Market Cap
€440.31M
€768.08M
Enterprise Value
€502.84M
€535.62M
PS Ratio
3.08
7.25

Enterprise valuationIndustry

EV / Sales
3.52
4.04

Share statisticsIndustry

Float
154M
79M
Shares Held by Insiders
11.0%
9.05%
Shares Held by Institutions
2.18%
20.8%

Short sellingIndustry

Short Interest
47,986
–
Short Interest Change
-75.0%
-2.55%
Days to Cover
2.05
3.54

Stock price statisticsIndustry

Price Change (1 Week)
2.72%
0.08%
Price Change (1 Month)
-4.23%
-2.76%
Price Change (3 Months)
-19.8%
-21.7%
Price Change (6 Months)
-0.35%
-11.3%
Price Change (YTD)
-35.8%
-15.5%
Price Change (1 Year)
-38.4%
-17.6%
Price Change (3 Years)
-57.2%
-8.10%
Price Change (5 Years)
-88.3%
-54.7%
Average Volume (10 Days)
12,474
–
Average Volume (20 Days)
18,700
–
Average Volume (90 Days)
60,712
–
Relative Volume
0.04
0.63
Relative Strength Index (14)
48.4
48.4
Volatility (1 Year)
66.4%
65.2%
Beta (5 Years)
1.67
0.86

MarginsIndustry

Gross Margin
16.4%
42.5%
Operating Margin
-80.5%
-33.2%
Pretax Margin
-110.2%
-36.6%
EBITDA Margin
-80.5%
-28.6%
FCF Margin
-40.6%
-24.4%

Returns on capitalIndustry

Return on Capital Employed (ROCE)
-40.4%
-23.8%

Financial positionIndustry

Current Ratio
2.16
3.49
Quick Ratio
1.33
1.51
Interest Coverage
-2.83
-0.71

GrowthIndustry

Revenue Growth (YoY)
-27.2%
-1.08%
Revenue Growth (3Y CAGR)
-21.5%
1.61%
Revenue Growth (5Y CAGR)
9.62%
14.0%

EfficiencyIndustry

Asset Turnover
0.33
0.31
Inventory Turnover
2.17
1.36
Revenue Per Employee
€1.02M
€855.98K
Employee Count
140
304
WACC
13.0%
9.49%

Income statement (TTM)Industry

Revenue
€142.94M
€465.66M
Gross Profit
€23.44M
€1.08B
Operating Income
-€115.11M
-€54.01M
Pretax Income
-€157.57M
-€47.40M
EBITDA
-€115.11M
-€42.85M

Balance sheetIndustry

Cash & Short-Term Investments
€121.53M
€199.29M
Total Debt
€184.06M
€184.06M
Net Cash (Debt)
-€62.53M
€111.50M
Net Cash Per Share
-0.36 EUR
1.53 EUR
Working Capital
€119.55M
€119.55M

Cash flow (TTM)Industry

Operating Cash Flow
-€55.69M
-€42.16M
Capital Expenditures
-€2.34M
-€2.34M
Free Cash Flow
-€58.04M
-€52.90M
FCF Per Share
-0.33 EUR
-0.48 EUR

Dividends and yieldsIndustry

FCF Yield
-13.2%
-13.3%

Taxes and interestIndustry

Interest Expense
€40.60M
€55.20M
Income Tax
€80.00K
€80.00K

Scores and fair valueIndustry

Altman Z-Score
0.62
1.23

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodVALNS&P 500DifferenceVALN per yearS&P 500 per year
1 month+1.8%-3.0%+4.8 pts
3 months+0.2%-2.8%+3.0 pts
Year to date-35.8%+11.5%−47.3 pts
1 year-38.7%+13.5%−52.1 pts
3 years-58.8%+77.7%−136.5 pts-25.6%+21.1%
5 years-88.3%+72.6%−160.9 pts-34.8%+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M VALN shares were sold short on Oct 30, 2026, down 75.0% from the previous report. At recent volumes it would take 2.0 days to buy them back. Over the last 20 sessions, 36.0% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202647,986-75.0%23,3842.0
Oct 15, 2026191,916-7.2%24,8587.7
Sep 30, 2026206,846+7.9%21,5689.6
Sep 15, 2026191,759-1.2%39,6874.8
Aug 31, 2026194,066+20.9%43,0424.5
Aug 14, 2026160,474+1.1%300,8171.0
Jul 31, 2026158,672-4.1%20,3397.8
Jul 15, 2026165,539-9.1%27,3096.1
Jun 30, 2026182,102+7.9%21,8058.3
Jun 15, 2026168,817-6.7%24,7696.8
May 29, 2026181,003+13.8%43,0924.2
May 15, 2026159,050+4.3%40,1244.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?